ARTV 8-K 2026-09-11

Artiva Biotherapeutics, Inc. (ARTV) 8-K dated 2026-09-11 — accession 0001193125-26-389308. This URL is the filing, not the ARTV hub.

Artiva Biotherapeutics, Inc. (ARTV) is a biotechnology company listed on US.

Artiva Biotherapeutics, Inc. filed a 8-K on 2026-09-11. Accession 0001193125-26-389308.

Cached items: 5.02, 5.07, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.

Not investment advice. The ARTV SEC hub lists recent forms. The stock page is the research view.